172 related articles for article (PubMed ID: 35691795)
1. Interferon-stimulated and metallothionein-expressing macrophages are associated with acute and chronic allograft dysfunction after lung transplantation.
Moshkelgosha S; Duong A; Wilson G; Andrews T; Berra G; Renaud-Picard B; Liu M; Keshavjee S; MacParland S; Yeung J; Martinu T; Juvet S
J Heart Lung Transplant; 2022 Nov; 41(11):1556-1569. PubMed ID: 35691795
[TBL] [Abstract][Full Text] [Related]
2. Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression.
Calabrese DR; Ekstrand CA; Yellamilli S; Singer JP; Hays SR; Leard LE; Shah RJ; Venado A; Kolaitis NA; Perez A; Combes A; Greenland JR
J Heart Lung Transplant; 2024 Jul; 43(7):1074-1086. PubMed ID: 38367738
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Persistence of Donor Alveolar Macrophages in Human Lung Transplant Recipients That Influences Donor-Specific Immune Responses.
Nayak DK; Zhou F; Xu M; Huang J; Tsuji M; Hachem R; Mohanakumar T
Am J Transplant; 2016 Aug; 16(8):2300-11. PubMed ID: 27062199
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein expression in human lung and its varying levels after lung transplantation. Toulouse Lung Transplantation Group.
Courtade M; Carrera G; Paternain JL; Martel S; Carre PC; Folch J; Pipy B
Chest; 1998 Feb; 113(2):371-8. PubMed ID: 9498954
[TBL] [Abstract][Full Text] [Related]
5. BAL Fluid Eosinophilia Associates With Chronic Lung Allograft Dysfunction Risk: A Multicenter Study.
Todd JL; Weber JM; Kelly FL; Neely ML; Mulder H; Frankel CW; Nagler A; McCrae C; Newbold P; Kreindler J; Palmer SM
Chest; 2023 Sep; 164(3):670-681. PubMed ID: 37003354
[TBL] [Abstract][Full Text] [Related]
6. Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
Levy L; Huszti E; Ahmed M; Ghany R; Hunter S; Moshkelgosha S; Zhang CYK; Boonstra K; Klement W; Tikkanen J; Singer LG; Keshavjee S; Juvet S; Martinu T
J Heart Lung Transplant; 2021 Dec; 40(12):1540-1549. PubMed ID: 34215500
[TBL] [Abstract][Full Text] [Related]
7. Role of passenger leukocytes in allograft rejection: effect of depletion of donor alveolar macrophages on the local production of TNF-alpha, T helper 1/T helper 2 cytokines, IgG subclasses, and pathology in a rat model of lung transplantation.
Sekine Y; Bowen LK; Heidler KM; Van Rooijen N; Brown JW; Cummings OW; Wilkes DS
J Immunol; 1997 Oct; 159(8):4084-93. PubMed ID: 9378999
[TBL] [Abstract][Full Text] [Related]
8. Priming donor lungs with thioredoxin-1 attenuates acute allograft injury in a rat model of lung transplantation.
Hu H; Lu L; Mu W; Johnson RJ; Block ER; Patel JM
J Heart Lung Transplant; 2008 Oct; 27(10):1142-9. PubMed ID: 18926407
[TBL] [Abstract][Full Text] [Related]
9. Inflammation on bronchoalveolar lavage cytology is associated with decreased chronic lung allograft dysfunction-free survival.
Greenland NY; Deiter F; Calabrese DR; Hays SR; Kukreja J; Leard LE; Kolaitis NA; Golden JA; Singer JP; Greenland JR
Clin Transplant; 2022 Jun; 36(6):e14639. PubMed ID: 35246990
[TBL] [Abstract][Full Text] [Related]
10. Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection.
Agostini C; Calabrese F; Rea F; Facco M; Tosoni A; Loy M; Binotto G; Valente M; Trentin L; Semenzato G
Am J Pathol; 2001 May; 158(5):1703-11. PubMed ID: 11337368
[TBL] [Abstract][Full Text] [Related]
11. Lung Allograft Microbiome Association with Gastroesophageal Reflux, Inflammation, and Allograft Dysfunction.
Schneeberger PHH; Zhang CYK; Santilli J; Chen B; Xu W; Lee Y; Wijesinha Z; Reguera-Nuñez E; Yee N; Ahmed M; Boonstra K; Ramendra R; Frankel CW; Palmer SM; Todd JL; Martinu T; Coburn B
Am J Respir Crit Care Med; 2022 Dec; 206(12):1495-1507. PubMed ID: 35876129
[No Abstract] [Full Text] [Related]
12. Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction.
Shino MY; Todd JL; Neely ML; Kirchner J; Frankel CW; Snyder LD; Pavlisko EN; Fishbein GA; Schaenman JM; Mason K; Kesler K; Martinu T; Singer LG; Tsuang W; Budev M; Shah PD; Reynolds JM; Williams N; Robien MA; Palmer SM; Weigt SS; Belperio JA
Am J Transplant; 2022 Sep; 22(9):2169-2179. PubMed ID: 35634722
[TBL] [Abstract][Full Text] [Related]
13. Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation.
Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Huynh RH; Saggar R; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2017 May; 17(5):1294-1303. PubMed ID: 27676455
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of gene expression profiling of bronchoalveolar lavage cells in acute lung allograft rejection.
Weigt SS; Wang X; Palchevskiy V; Li X; Patel N; Ross DJ; Reynolds J; Shah PD; Danziger-Isakov LA; Sweet SC; Singer LG; Budev M; Palmer S; Belperio JA
J Heart Lung Transplant; 2019 Aug; 38(8):845-855. PubMed ID: 31122726
[TBL] [Abstract][Full Text] [Related]
15. Effector immune cells in chronic lung allograft dysfunction: A systematic review.
Bos S; Filby AJ; Vos R; Fisher AJ
Immunology; 2022 May; 166(1):17-37. PubMed ID: 35137398
[TBL] [Abstract][Full Text] [Related]
16. The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection.
Combs MP; Luth JE; Falkowski NR; Wheeler DS; Walker NM; Erb-Downward JR; Wakeam E; Sjoding MW; Dunlap DG; Admon AJ; Dickson RP; Lama VN
Am J Respir Crit Care Med; 2024 Jun; 209(11):1360-1375. PubMed ID: 38271553
[No Abstract] [Full Text] [Related]
17. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
[TBL] [Abstract][Full Text] [Related]
18. The autotaxin-lysophosphatidic acid pathway mediates mesenchymal cell recruitment and fibrotic contraction in lung transplant fibrosis.
Sinclair KA; Yerkovich ST; Hopkins PM; Fieuw AM; Ford P; Powell JE; O'Sullivan B; Chambers DC
J Heart Lung Transplant; 2021 Jan; 40(1):12-23. PubMed ID: 33339555
[TBL] [Abstract][Full Text] [Related]
19. Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care.
Keller M; Sun J; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S
J Heart Lung Transplant; 2022 Apr; 41(4):458-466. PubMed ID: 35063338
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of inflammatory cytokines and adhesion molecules by alveolar macrophages of human lung allograft recipients with acute rejection: decline with resolution of rejection.
Rizzo M; SivaSai KS; Smith MA; Trulock EP; Lynch JP; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2000 Sep; 19(9):858-65. PubMed ID: 11008075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
